Stomatitis Flashcards
(8 cards)
Explain what kind of host response to periodontal plaque is considered aberrant and may be an explanation for FCGS
Cats with idiopathic stomatitis have a tendency to develop an antibody-dominant immune response in the oral cavity, compared with healthy cats where a more balanced or cell-mediated immune response predominates
What was revealed by the study of the polyclonal gammopathy
Examination of the polyclonal gammopathy in many cats with stomatitis has revealed that this is due, at least in part, to elevated antibody concentrations against oral anaerobic bacteria
- this finding emphasizes the importance of the oral bacterial flora in provoking inflammation
What is the supposed pathomechanism for chronic stomatitis-gingivitis
A persistent source of antigenic stimulation and host “hyper-reactivity” to that stimulus demonstrated by the non-specific plasmacytic-lymphocytic infiltration and the hypergammaglobulinemia
- a local immune response geared towards antibody production at the detriment of cell-mediated mechanisms appears to be one potential component
Which cases of CGS will have the most beneficial outcomes with tooth extraction
Cases where chronic gingivostomatitis exists concurrently with moderate to marked periodontal disease are most likely to benefit from total tooth extraction
What are the two clinical presentations for FCGS
There appear to be two clinical phenotypes of FCGS: ulcerative and proliferative
- some patients will display both
What is the hallmark for FCGS
The hallmark is inflammation that not only affects the gingiva but also extends to the alveolar and buccal mucosa
What immunologic finding confirms the implication of an intracellular organism in the pathogeny of FCGS
Memory CD8+ T cells are the principal component of immunity against intracellular pathogens such as viruses
- this means there is an unresolved inflammation in which CD8+ T cells are activated more than once and remain activated
The predominance of CD8+ T cells in lesions and increased circulatory effector memory cells in FCGS confirm that an intracellular organism (most likely a virus) causes inflammation
What are the clinical management goals for FCGS
The clinical management goals for FCGS are:
- to decrease or eliminate antigenic stimulation
- to modulate the abnormal immune response